Skip to content
Peregrine
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact

Amit Alfasi

Momentis Surgical

Memic announces completion of first patient cases using Hominis® Surgical System

Read More
Cordio Mecidal

Cordio Mecidal has completed a successful strategic Series C funding round raising a total of $18M

Read More
Peregrine

Magneto Thrombectomy Solutions announces a successful First-in-Human

Read More
Cordio Mecidal

Ribon Therapeutics to present at the 2022 American Association for Cancer Research annual meeting

Read More
Catiheal - Nir Altschuler

CartiHeal is acquired by Bioventus

Read More

Aleph Farms expands to new headquarters in Rehovot, Israel’s “biotech hub”

Read More
Variantyx

Variantyx secured $41.5M in series C funding round

Read More
CardioValve

CardioValve is acquired by Venus Medtech

Read More
MedTech Money - Eyal Lifschitz

MedTech Money Podcast – The First Dedicated Medtech Venture Fund in Israel: The Story of “Startup Nation”

Read More
Momentis Surgical - Dvir Cohen

Memic Surgical announces the sale of Hominis® Surgical System

Read More
Page1 Page2 Page3 Page4 Page5
  • Homepage
  • About Us
  • Our Funds
  • Portfolio
  • Team
  • ESG AND IMPACT
  • News
  • Contact
  • Homepage
  • About Us
  • Our Funds
  • Portfolio
  • Team
  • ESG AND IMPACT
  • News
  • Contact
Linkedin-in
  • Terms of Use
  • Privacy Policy
  • Accessibility Statment
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Accessibility Statment
  • Cookie Policy
©All rights reserved to Peregrine 2026

site by: 

razgroup-logo
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}